Eris Lifesciences Ltd ERIS-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 2:59 PM IST
710.55quote price arrow down-5.55 (-0.78%)
Volume
43,606
52 week range
623.05 - 863.00
Loading...
  • Open718.95
  • Day High718.95
  • Day Low702.20
  • Prev Close716.10
  • 52 Week High863.00
  • 52 Week High Date10/19/21
  • 52 Week Low623.05
  • 52 Week Low Date02/24/22

Key Stats

  • Market Cap1,252.76M
  • Shares Out135.93M
  • 10 Day Average Volume69,101.55
  • Dividend6.01
  • Dividend Yield0.85%
  • Beta-
  • YTD % Change-6.87

KEY STATS

  • Open718.95
  • Day High718.95
  • Day Low702.20
  • Prev Close716.10
  • 52 Week High863.00
  • 52 Week High Date10/19/21
  • 52 Week Low623.05
  • 52 Week Low Date02/24/22
  • Market Cap1,252.76M
  • Shares Out135.93M
  • 10 Day Average Volume69,101.55
  • Dividend6.01
  • Dividend Yield0.85%
  • Beta-
  • YTD % Change-6.87

RATIOS/PROFITABILITY

  • EPS (TTM)29.89
  • P/E (TTM)23.77
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/05/2021
  • Div Amount6.01
  • Split Date-
  • Split Factor-

Latest On Eris Lifesciences Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Eris Lifesciences Limited is an India-based company that is primarily engaged in the manufacturing and marketing of pharmaceutical products. The Company’s manufacturing plant is located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals and nutrients (VMN). The Company's brands include Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo...
Amit Bakshi
Chairman of the Board, Managing Director
Sachin Shah
Chief Financial Officer
Address
7th Floor, Commerce House IV,,
Beside Shell Petrol Pump, 100 Feet Road,
Ahmedabad
380015
India